As someone who is passionate about therapeutic advances in cannabis, I am particularly excited about Panama's historic decision. The resolution no. 372 of September 26, 2025 marks a decisive turning point for access to care in Latin America and inspires in-depth reflection on the future of medical cannabis in Europe.
📜 Regulatory Context: From Vagueness to Controlled Legalization
Panama laid the first foundations of its regulations with the Ley 242 of 2021, but it is really in 2025 that the framework becomes operational. Resolution No. 372, published in the Official Journal, puts an end to years of uncertainty by establishing clear procedures for the marketing of cannabis-based medicines.
“This resolution fills a crucial legal gap: it defines the technical requirements, prescribing conditions and control mechanisms for safe patient access.” – Source: Nouvelle Herbe
🛡️ Guarantees Required by the Panamanian Authorities
-
Complete technical file : including independent laboratory analysis certificates
-
Detailed labeling : composition, dosage, side effects and contraindications
-
Mandatory medical prescription : delivered by an authorized doctor
-
Control of the National Program for the Use of Medicinal Cannabis : rigorous supervision of the supply chain
💊 Concrete Impacts for Panamanian Patients
In my experience with users of therapeutic CBD, I have noticed to what extent a reassuring legal framework transforms the relationship with care. Imagine a patient suffering from chronic pain who can finally obtain their treatment without fear of prosecution, with the support of a healthcare professional.
Documented benefits of medical cannabis include:
- Chronic pain relief (WHO 2023 studies)
- Reduction of resistant epileptic seizures
- Improved sleep and reduced anxiety
- Complement to conventional treatments
🌍 International Implications and Inspiration for Europe
This Panamanian advance is part of a global trend of recognition of the therapeutic virtues of cannabis. For us, European CBD stakeholders, it demonstrates that balanced regulation between accessibility and security is possible.
In France, where the debate on medical cannabis remains lively, the Panamanian example shows the importance:
- Establish clear prescription protocols
- To guarantee the traceability and quality of products
- To involve health professionals in the process
🚀 CBD Tech: Your Trusted Partner in Therapeutic CBD
With 5 years of expertise and collaboration with certified laboratories, we are inspired by these regulatory advances to offer ever more innovative and safe products.
Specially designed to meet demanding therapeutic needs, our powerful CBD collection combines high concentrations and optimal purity.
🌿 Full Spectrum Oils with 60% CBD
🔬 Certificates of analysis available for each batch
💯 Compliance with the strictest European standards
🚚 Free delivery from 59€ purchase
From €49.90
Discover the Collection
🔮 Future Perspectives: Panama, Regional Precursor?
According to Newsroom Panama, the National Program for the Use of Medicinal Cannabis will face several challenges:
“Financial access remains a major concern, as does the training of prescribing doctors. But the political will is there to make Panama a regional leader in medical cannabis.” – Source: Newsroom Panama
🎯 Ready to Explore the Benefits of Therapeutic CBD?
The legalization of cannabis-based medicines in Panama marks significant progress for patients and the industry. At CBD Tech, we are carefully following these developments which are shaping the future of medical cannabis in Europe.
Our team of experts supports you in choosing the products best suited to your needs.
Discover Our Premium Collection
i️ Important information: This article is based on official sources as of November 10, 2025. It is for informational purposes and does not constitute medical advice. Consult a healthcare professional before using CBD products. CBD Tech products comply with French legislation with a THC level of less than 0.3%.
